Contour Neurovascular System for Brain Aneurysm
(NECC Trial)
Recruiting in Palo Alto (17 mi)
+20 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Cerus Endovascular, Inc.
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
Research Team
Pascal M Jabbour, MD
Principal Investigator
Jefferson University Hospitals
DL
Demetrius Lopes, MD
Principal Investigator
Advocate Medical Group - Brain and Spine Institute
Eligibility Criteria
This trial is for adults aged 18-75 with certain wide-necked brain aneurysms sized between 2 and 10.5 mm that require repair, who can follow the study schedule. Excluded are those on non-stop anticoagulants, with severe kidney issues not on dialysis, pregnant or breastfeeding women, participants in other conflicting studies, individuals allergic to device materials or contrast dye, and those with conditions affecting study compliance.Inclusion Criteria
I am between 18 and 75 years old.
Patient or legally authorized representative has signed and dated an institutional review board (IRB)/Ethics Committee (EC)-approved written informed consent prior to initiation of any study procedures
If you have had a burst blood vessel in your brain, you must meet the guidelines from the American Heart Association and American Stroke Association for how it should be managed.
See 13 more
Exclusion Criteria
Target IA contains other devices/implants (e.g., coils) that could interfere with the correct placement of the Contour device
I have had symptoms or conditions that increase my risk of a stroke in the last 2 months.
I am on blood thinners that I cannot stop taking.
See 14 more
Treatment Details
Interventions
- Contour NEurovasCular System™ (Procedure)
Trial OverviewThe Contour Neurovascular System™ is being tested for its safety and effectiveness in repairing wide-necked bifurcated saccular intracranial aneurysms. The data collected will support a premarket approval application to the FDA.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Attempted to TreatExperimental Treatment1 Intervention
Attempted to treat (ATT) with the investigational device
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Alejandro SpiottaCharleston, SC
University of ChicagoChicago, IL
Alejandro SpiottaCharelston, SC
Medical City PlanoPlano, TX
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Cerus Endovascular, Inc.
Lead Sponsor
Trials
7
Patients Recruited
600+
Cerus Endovascular, Ltd
Lead Sponsor
Trials
6
Patients Recruited
350+